Macrovic (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

The formulation provides sodium, potassium, chloride and bicarbonate ions that directly replenish depleted electrolyte stores. Macrogol 3350 remains in the intestinal lumen, creating an osmotic gradient that draws water into the bowel, which softens stool and promotes regular bowel movements while supporting acid‑base balance.

The dose of Macrovic is individualized. A qualified prescriber determines the appropriate volume based on the patient’s degree of dehydration, electrolyte status, age, weight and clinical condition. The prescribing information provides guidance, but the exact regimen should be set by a healthcare professional.

Safety data for Macrovic in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should evaluate the clinical situation and discuss potential risks with the patient before prescribing.

To request Macrovic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Macrovic combines a full electrolyte profile (sodium, potassium, chloride, bicarbonate) with macrogol 3350, an osmotic agent. Compared with standard oral rehydration salts that lack a laxative component, Macrovic also addresses constipation. The choice depends on whether simultaneous bowel cleansing is desired alongside rehydration.

Macrovic should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Follow any additional handling instructions on the label to maintain product stability.

Macrovic is taken orally as a liquid solution. The prescribed volume is measured using the provided dosing device or a calibrated syringe and consumed directly or mixed with a small amount of water, as directed by the prescriber. It should be taken with or without food according to clinical guidance.

Serious risks include severe dehydration if excessive fluid loss occurs, significant electrolyte disturbances such as hypernatremia or hyperkalemia, and allergic reactions that may present as rash, swelling or breathing difficulty. Patients should be monitored for these events, especially when large volumes are administered.

Macrovic is contraindicated in individuals with known hypersensitivity to any of its components, those with complete intestinal obstruction, and patients in whom fluid overload could be hazardous, such as certain cases of severe heart or renal failure. Clinicians must assess each patient’s condition before prescribing.